Safety, formulation, and in vitro antiviral activity of the antimicrobial peptide subtilosin against herpes simplex virus type 1.
about
Antimicrobial Peptides as Potential Alternatives to Antibiotics in Food Animal IndustryAntiherpes simplex virus type 2 activity of the antimicrobial peptide subtilosinAntimicrobial potential of bacteriocins in poultry and swine production.Evaluation of a nisin-eluting nanofiber scaffold to treat Staphylococcus aureus-induced skin infections in mice.Polyethylene glycol-based hydrogels for controlled release of the antimicrobial subtilosin for prophylaxis of bacterial vaginosis.On bacteriocin delivery systems and potential applications.Antiviral potential of lactic acid bacteria and their bacteriocins.Antimicrobial peptides: an alternative for innovative medicines?Antimicrobial peptides of the genus Bacillus: a new era for antibiotics.In vitro antiviral activity of Lactobacillus casei and Bifidobacterium adolescentis against rotavirus infection monitored by NSP4 protein production.Antiviral Effects of Lactococcus lactis on Feline Calicivirus, A Human Norovirus Surrogate.Anti-influenza Activity of a Bacillus subtilis Probiotic Strain.Antimicrobial Nanomaterials Derived from Natural Products-A Review.Draft Genome Sequence of Bacillus subtilis strain KATMIRA1933.Antifungal nanofibers made by controlled release of sea animal derived peptide.2,3-Dihydroxybenzoic acid electrospun into poly(D,L-lactide) (PDLLA)/poly(ethylene oxide) (PEO) nanofibers inhibited the growth of Gram-positive and Gram-negative bacteria.In-silico design and molecular docking evaluation of peptides derivatives from bacteriocins and porcine beta defensin-2 as inhibitors of Hepatitis E virus capsid protein.Bacteriocinogenic LAB Strains for Fermented Meat Preservation: Perspectives, Challenges, and Limitations.Probiotics and antimicrobial peptides: the creatures' and substances' future in the twenty-first century: an opinion letter.Nanostructures for delivery of natural antimicrobials in food.Subtilosin Prevents Biofilm Formation by Inhibiting Bacterial Quorum Sensing.
P2860
Q26751499-FE1CC31F-6281-4485-9A00-058331BBADC7Q34345122-C91E7391-37D5-4A12-9896-0FF537A44D04Q36343945-EA850C15-70E9-43C0-9314-0FD68B6B6DBAQ37036569-80BE911C-EE5C-497A-9801-23D8263E3EA7Q37713013-EEDB496A-0237-41D2-A150-96A60E80207CQ38191238-A9A4F7CE-D824-4870-8967-35E7C0EAD2B0Q38216309-84B5882D-3A86-40FE-B61A-E59E67595227Q38317511-7940C126-D6D6-4144-9FA5-DC8271705E07Q38335550-E27B9B4F-1F84-4E14-AB1C-F178070F0606Q38800371-DBC0AAFE-E4BB-4900-A2E5-B1464DCCB9F4Q38965404-B7CFA0F0-6B44-42EA-84F1-452E575E42A1Q40239527-CFE1C29E-851A-47BB-A99E-93807E9F158CQ40738903-F8137FC3-F2E5-4EF5-9138-6E4C53A828C2Q40905690-B508A310-4E19-4567-BF47-0E074EC9887FQ41209461-5BDEE932-9E0D-4CFB-A1C1-FFD8433D5693Q42210271-796336D1-D767-4BEB-B64C-47264D1F6836Q47240941-B2EBB85C-0FE7-4FA2-A065-877A4E3300F0Q47786977-09A50746-3010-4399-9424-F5B57824C1E6Q48924009-E4D3A31E-A2F3-44B5-882C-7B3766739CE4Q51064899-42053059-42A8-4441-92B7-67507BBF7072Q51287837-513AF55C-CEE6-47FA-A478-72B03BB6EE18
P2860
Safety, formulation, and in vitro antiviral activity of the antimicrobial peptide subtilosin against herpes simplex virus type 1.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Safety, formulation, and in vi ...... t herpes simplex virus type 1.
@ast
Safety, formulation, and in vi ...... t herpes simplex virus type 1.
@en
type
label
Safety, formulation, and in vi ...... t herpes simplex virus type 1.
@ast
Safety, formulation, and in vi ...... t herpes simplex virus type 1.
@en
prefLabel
Safety, formulation, and in vi ...... t herpes simplex virus type 1.
@ast
Safety, formulation, and in vi ...... t herpes simplex virus type 1.
@en
P2093
P2860
P1476
Safety, formulation, and in vi ...... st herpes simplex virus type 1
@en
P2093
Katia Sutyak Noll
Mónica B Wachsman
Nicolás I Torres
Qingrong Huang
P2860
P2888
P356
10.1007/S12602-012-9123-X
P577
2013-03-01T00:00:00Z